We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

18 hedge funds and large institutions have $51.2M invested in Tonix Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

20% more funds holding

Funds holding: 1518 (+3)

0% more ownership

Funds ownership: 0%0% (+0%)

40% less capital invested

Capital invested by funds: $85.3M → $51.2M (-$34.1M)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$15K
GG
52
Gofen & Glossberg
Illinois
$15K
Two Sigma Investments
53
Two Sigma Investments
New York
$13K
EH
54
Equitable Holdings
New York
$12K
HWA
55
HCR Wealth Advisors
California
$12K
Mackenzie Financial
56
Mackenzie Financial
Ontario, Canada
$12K
SGI
57
Summit Global Investments
Utah
$12K
CCB
58
Cutter & Co Brokerage
Missouri
$11K
VHAM
59
Van Hulzen Asset Management
California
$11K
Squarepoint
60
Squarepoint
New York
$10K
X
61
Xponance
Pennsylvania
$10K
BCM
62
Bridgeway Capital Management
Texas
$9K
PWM
63
Purus Wealth Management
California
$9K
SWM
64
Spire Wealth Management
Virginia
$9K
Wells Fargo
65
Wells Fargo
California
$9K
TRCT
66
Tower Research Capital (TRC)
New York
$7K
ZIG
67
Zuckerman Investment Group
Illinois
$7K
PHK
68
Point72 Hong Kong
Hong Kong
$6K
PA
69
Profund Advisors
Maryland
$6K
SAF
70
Smith Anglin Financial
Texas
$6K
CSS
71
Cubist Systematic Strategies
Connecticut
$5K
FDCDDQ
72
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3K
HI
73
Harbour Investments
Wisconsin
$3K
BWL
74
Bogart Wealth LLC
Virginia
$1K
GI
75
Gradient Investments
Minnesota
$1K

TNXP Hedge Fund Activity: Q3 2021 in Review

18 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q3 2021, worth a combined $51.2M — down 40% from $85.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TNXP positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $4.38M. The largest seller was Norges Bank, exiting entirely with an estimated $3.06M sold.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q3 2021, up from 15 in Q2 2021.
  • Funds reported $51.2M of Tonix Pharmaceuticals stock for Q3 2021, down 40% quarter-over-quarter.
  • 6 funds opened new Tonix Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q3 2021 was D.E. Shaw & Co, an estimated $4.38M added.
  • The largest Tonix Pharmaceuticals seller in Q3 2021 was Norges Bank, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2021.